1. Market Research
  2. > Pharmaceutical
  3. > Drug Delivery Market Trends
  4. > Global Drug-Eluting Stent Market 2016-2020

Global Drug-Eluting Stent Market 2016-2020

  • February 2016
  • -
  • Infiniti Research Limited
  • -
  • 56 pages

About Drug-Eluting Stent

Drug-eluting stents, also known as medicated coronary stents, are used to inhibit artery blockages that may occur in patients after an angioplasty surgery. A drug-eluting stent is a tiny, expandable metal mesh tube, which is covered with a pharmacologic agent (drug). Drug-eluting stents are used to treat patients that suffer from atherosclerosis that can occur because of hypertension, smoking, a sedentary lifestyle, or a high-cholesterol diet. After a patient undergoes angioplasty, there is a chance that the artery might close again because of blood clots or excessive growth of the surrounding tissues. To address this problem, drug-eluting stents are placed in the artery, preventing it from narrowing or clogging. Thus, drug-eluting stents eliminate the need for repeated revascularization procedures that are used to treat restenosis (narrowing of blood vessels). Restenosis of an artery occurs because of the body’s natural immune response to an injury. Drug-eluting stents help in reducing the arterial blockage and ensure smooth blood flow through the arteries.

Technavio’s analysts forecast the global drug-eluting stent market to grow at a CAGR of 3.45% during the period 2016-2020.

Covered in this report
The report covers the present scenario and the growth prospects of the global drug-eluting stent market for 2016-2020. To calculate the market size, the report considers the revenue generated from the sales of drug-eluting stent products.


The market is divided into the following segments based on geography:
- Americas
- APAC
- EMEA

Technavio's report, Global Drug-Eluting Stent Market 2016-2020, has been prepared based on an in-depth market analysis with inputs from industry experts. The report covers the market landscape and its growth prospects over the coming years. The report also includes a discussion of the Key vendorsoperating in this market.

Key vendors
- Abbott Laboratories
- Biosensors International Group
- Boston Scientific
- Medtronic
- Terumo Corporation


Other prominent vendors
- Biotronik
- Cook Medical
- Envision Scientific
- Lepu Medical
- Meril Life Sciences
- MicroPort Medical
- Opto Circuits
- Shandong JW Medical Systems
- STENTYS

Market driver
- High prevalence of atherosclerosis diseases
- For a full, detailed list, view our report

Market challenge
- Decline in price of drug-eluting stent
- For a full, detailed list, view our report

Market trend
- Increasing partnership and collaboration activities
- For a full, detailed list, view our report

Key questions answered in this report
- What will the market size be in 2020 and what will the growth rate be?
- What are the key market trends?
- What is driving this market?
- What are the challenges to market growth?
- Who are the key vendors in this market space?
- What are the market opportunities and threats faced by the key vendors?
- What are the strengths and weaknesses of the key vendors?

You can request one free hour of our analyst’s time when you purchase this market report. Details are provided within the report.

Table Of Contents

Global Drug-Eluting Stent Market 2016-2020
PART 01: Executive summary
- Highlights
PART 02: Scope of the report
- Market overview
- Top-vendor offerings
PART 03: Market research methodology
- Research methodology
- Economic indicators
PART 04: Introduction
- Key market highlights
PART 05: Drug-eluting stents: An overview
PART 06: Market landscape
- Market overview
- Market size and forecast
- Five forces analysis
PART 07: Drugs employed in drug-eluting stents
PART 08: Geographical segmentation
- Drug-eluting stent market in Americas
- Drug-eluting stent market in EMEA
- Drug-eluting stent market in APAC
PART 09: Key leading countries
- US
- China
- Germany
- Japan
PART 10: Market drivers
- High prevalence of atherosclerosis diseases
- Favorable reimbursement scenario
- Reduced risk of contracting restenosis
- Technological advancements
PART 11: Impact of drivers
PART 12: Market challenges
- Decline in price of drug-eluting stents
- Availability of alternative procedures
- Preference for drugs over stents
- Risk of late-stage thrombosis
PART 13: Impact of drivers and challenges
PART 14: Market trends
- Increasing partnership and collaboration activities
- Growing popularity of hybrid procedures
- Growing focus on emerging countries
PART 15: Vendor landscape
- Competitive scenario
- Market share analysis 2015
- Key vendor analysis
- Abbott Laboratories
- Biosensors International
- Boston Scientific
- Medtronic
- Terumo
- Other prominent vendors
PART 16: Appendix
- List of abbreviations
PART 17: Explore Technavio


List of Exhibits
Exhibit 01: Product offerings
Exhibit 02: Treatment options: Percutaneous coronary intervention
Exhibit 03: Cross section of a stent
Exhibit 04: Agents used in drug-eluting stents
Exhibit 05: History of drug-eluting stent
Exhibit 06: Global drug-eluting stent market 2015-2020 ($ billions)
Exhibit 07: Five forces analysis
Exhibit 08: Classification of drugs used in drug-eluting stents
Exhibit 09: Segmentation of global drug-eluting stent market by geography 2015
Exhibit 10: Segmentation of global drug-eluting stent market by geography 2020
Exhibit 11: Segmentation of global drug-eluting stent market by geography 2015-2020
Exhibit 12: Drug-eluting stent market in Americas 2015-2020 ($ billions)
Exhibit 13: Drug-eluting stent market in EMEA 2015-2020 ($ billions)
Exhibit 14: Drug-eluting stent market in APAC 2015-2020 ($ billions)
Exhibit 15: Key leading countries
Exhibit 16: Market share of key leading countries in global drug-eluting stent market 2015
Exhibit 17: List of major biodegradable-coated drug-eluting stent products 2015
Exhibit 18: Impact of drivers
Exhibit 19: Impact of drivers and challenges
Exhibit 20: Estimated healthcare spending in BRIC countries in 2015 ($ billions)
Exhibit 21: Abbott Laboratories: Key takeaways
Exhibit 22: Biosensors International: Business segmentation by revenue 2015
Exhibit 23: Biosensors International: Key takeaways
Exhibit 24: Boston Scientific: Business segmentation by revenue 2014
Exhibit 25: Boston Scientific: Geographical segmentation by revenue 2014
Exhibit 26: Boston Scientific: Key takeaways
Exhibit 27: Medtronic: Key takeaways
Exhibit 28: Terumo: Key takeaways

View This Report »

Get Industry Insights. Simply.

  • Latest reports & slideshows with insights from top research analysts
  • 24 Million searchable statistics with tables, figures & datasets
  • More than 10,000 trusted sources
24/7 Customer Support

Talk to Veronica

+1 718 514 2762

Purchase Reports From Reputable Market Research Publishers
Drug Eluting Stent Market, By Polymer-based Coatings, Polymer-free Coatings, By Application, And Segment Forecasts To 2024

Drug Eluting Stent Market, By Polymer-based Coatings, Polymer-free Coatings, By Application, And Segment Forecasts To 2024

  • $ 4950
  • Industry report
  • August 2016
  • by Grand View Research

The global drug eluting stent market is anticipated to reach USD 9.2 billion by 2024, according to a new report by Grand View Research, Inc. The increasing geriatric population and the high prevalence ...

Bioabsorbable Stents - Global Market Outlook (2016-2022)

Bioabsorbable Stents - Global Market Outlook (2016-2022)

  • $ 4157
  • Industry report
  • October 2016
  • by Stratistics MRC

According to Stratistics MRC, the Global Bioabsorbable Stents Market is accounted for $0.35 billion in 2015 and is expected to reach $3.56 billion by 2022 growing at a CAGR of 39.2% during the forecast ...

Drug Eluting Stents Market Analysis & Trends- Product (Polymer-based Coatings, Non biodegradable Polymers, Nanoporous Surface and Polymer free Coatings)and Drugs Used (Anti-neoplastics, Immunosupressives and Enhanced Healing Factors) - Forecast to 2025

Drug Eluting Stents Market Analysis & Trends- Product (Polymer-based Coatings, Non biodegradable Polymers, Nanoporous Surface and Polymer free Coatings)and Drugs Used (Anti-neoplastics, Immunosupressives and Enhanced Healing Factors) - Forecast to 2025

  • $ 4200
  • Industry report
  • November 2016
  • by Accuray Research LLP

The Global Drug Eluting Stents Market is poised to grow at a CAGR of around 3.8% over the next decade to reach approximately $9.45 billion by 2025. Some of the prominent trends that the market is Recent ...


ref:plp2016

Reportlinker.com © Copyright 2016. All rights reserved.

ReportLinker simplifies how Analysts and Decision Makers get industry data for their business.